Drug Type Antibody drug conjugate (ADC) |
Synonyms BL-B005A2 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 1 | US | Systimmune, Inc.Startup | 11 Jan 2021 |
Non-Small Cell Lung Cancer | Phase 1 | US | Systimmune, Inc.Startup | 11 Jan 2021 |